Related Experiment Video
Updated: Feb 6, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Intraocular use of bevacizumab in India: An issue resolved?
Atul Kumar1, Koushik Tripathy1, Rohan Chawla1
1Dr R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi 110029, India.
Abstract:
Bevacizumab is a monoclonal antibody against vascular endothelial growth factor (VEGF), which has been approved for intravenous use in certain cancers. There is evidence of its efficacy and safety as an intravitreal drug compared with ranibizumab and aflibercept. We have, in our practice, found it to be a cost-effective treatment option for ocular diseases, which could save a large amount of public money used in various national health insurance systems. An alert issued by the Drug Controller General of India led to a virtual ban on its intraocular use in India. However, pro-active advocacy and leadership by national ophthalmological societies helped to resolve the issue quickly.
Related Concept Videos
Ethical Issues
Ethical Concerns in Healthcare:
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Restarting Stalled Replication Forks
Social Loafing
Proofreading
Social Traps

